Hommes OR - Search Results

1

Limited duration of the effect of methylprednisolone on changes on MRI in multiple sclerosis.

Barkhof F, Tas MW, Frequin ST, Scheltens P, Hommes OR, Nauta JJ, Valk J. Barkhof F, et al. Among authors: hommes or. Neuroradiology. 1994 Jul;36(5):382-7. doi: 10.1007/BF00612124. Neuroradiology. 1994. PMID: 7936181

2

A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Barkhof F, Frequin ST, Hommes OR, Lamers K, Scheltens P, van Geel WJ, Valk J. Barkhof F, et al. Among authors: hommes or. Neurology. 1992 Jan;42(1):63-7. doi: 10.1212/wnl.42.1.63. Neurology. 1992. PMID: 1370864

3

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.

Barkhof F, Scheltens P, Frequin ST, Nauta JJ, Tas MW, Valk J, Hommes OR. Barkhof F, et al. Among authors: hommes or. AJR Am J Roentgenol. 1992 Nov;159(5):1041-7. doi: 10.2214/ajr.159.5.1414773. AJR Am J Roentgenol. 1992. PMID: 1414773

4

The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.

Frequin ST, Barkhof F, Lamers KJ, Hommes OR. Frequin ST, et al. Among authors: hommes or. J Neuroimmunol. 1992 Oct;40(2-3):265-72. doi: 10.1016/0165-5728(92)90142-8. J Neuroimmunol. 1992. PMID: 1430156 Review.

5

Meningeal Gd-DTPA enhancement in multiple sclerosis.

Barkhof F, Valk J, Hommes OR, Scheltens P. Barkhof F, et al. Among authors: hommes or. AJNR Am J Neuroradiol. 1992 Jan-Feb;13(1):397-400. AJNR Am J Neuroradiol. 1992. PMID: 1595484 Free PMC article. No abstract available.

6

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T.

Barkhof F, Valk J, Hommes OR, Scheltens P, Nauta JJ. Barkhof F, et al. Among authors: hommes or. AJNR Am J Neuroradiol. 1992 Jul-Aug;13(4):1257-9. AJNR Am J Neuroradiol. 1992. PMID: 1636547 Free PMC article.

7

Quantitative MRI changes in gadolinium-DTPA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis.

Barkhof F, Hommes OR, Scheltens P, Valk J. Barkhof F, et al. Among authors: hommes or. Neurology. 1991 Aug;41(8):1219-22. doi: 10.1212/wnl.41.8.1219. Neurology. 1991. PMID: 1866009

8

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images.

van Walderveen MA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. van Walderveen MA, et al. Among authors: hommes or. Neurology. 1995 Sep;45(9):1684-90. doi: 10.1212/wnl.45.9.1684. Neurology. 1995. PMID: 7675227

9

The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.

Tas MW, Barkhol F, van Walderveen MA, Polman CH, Hommes OR, Valk J. Tas MW, et al. Among authors: hommes or. AJNR Am J Neuroradiol. 1995 Feb;16(2):259-64. AJNR Am J Neuroradiol. 1995. PMID: 7726070 Free PMC article.

10

T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone.

Frequin ST, Lamers KJ, Borm GF, Barkhof F, Jongen PJ, Hommes OR. Frequin ST, et al. Among authors: hommes or. Acta Neurol Scand. 1993 Aug;88(2):80-6. doi: 10.1111/j.1600-0404.1993.tb04195.x. Acta Neurol Scand. 1993. PMID: 8213063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,720 results

Search Page

Filters